Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: Report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011)

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 1, 2013, Pages 107-109

  Jones, Ronald N ^a   Sader, Helio S ^a   Mendes, Rodrigo E ^a   Flamm, Robert K ^a  

^a JMI LABORATORIES   (United States)

Author keywords

Ceftaroline; Resistance; S. pneumoniae; Vaccines

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFTAROLINE; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DRUG ACTIVITY; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; LONGITUDINAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREND STUDY; UNITED STATES;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 84870750520     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.08.024     Document Type: Article

References (14)

1. Chen D.K., McGeer A., de Azavedo J.C., Low D.E. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999, 341:233-239.
2. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - ninth edition, M07-A9 2012, CLSI, Wayne, PA.
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 23rd informational supplement (M100-S23) 2013, CLSI, Wayne, PA.
4. File T.M., Low D.E., Eckburg P.B., Talbot G.H., Friedland H.D., Lee J., et al. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010, 51:1395-1405.
5. Gertz R.E., Li Z., Pimenta F.C., Jackson D., Juni B.A., Lynfield R., et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010, 201:770-775.
6. Jacobs M.R., Good C.E., Windau A.R., Bajaksouzian S., Biek D., Critchley I.A., et al. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 2010, 54:2716-2719.
7. Jones R.N., Jacobs M.R., Sader H.S. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Int J Antimicrob Agents 2010, 36:197-204.
8. Jones R.N., Sader H.S., Moet G.J., Farrell D.J. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009). Diagn Microbiol Infect Dis 2010, 68:334-336.
9. Jones R.N., Farrell D.J., Mendes R.E., Sader H.S. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: Results from an international surveillance study. J Antimicrob Chemother 2011, 66(Suppl. 3):iii69-iii80.
10. Mera R., Miller L.A., Fritsche T.R., Jones R.N. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist 2008, 14:101-107.
11. Moet GJ, Biedenbach DJ, Jones RN, Stilwell MG. Secular trends in antimicrobial resistance among USA isolates of S. pneumoniae: a decade of experience from the SENTRY Antimicrobial Surveillance Program. In: ASM, May 21-25, 2007. Abstr. A-033. Toronto, Ontario, Canada. 2007.
12. Perez-Trallero E., Marimon J.M., Alonso M., Ercibengoa M., Garcia-Arenzana J.M. Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes. Antimicrob Agents Chemother 2012, 56:3989-3991.
13. Teflaro Package Insert New York City, NY Accessed June 2012. Available online. http://www.frx.com/pi/Teflaro_pi.pdf.
14. Zhanel G.G., Sniezek G., Schweizer F., Zelenitsky S., Lagace-Wiens P.R., Rubinstein E., et al. Ceftaroline: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Drugs 2009, 69:809-831.